The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain

INTRODUCTION: Bortezomib has been reported to favourably impact the outcomes of t(4;14) and del(17p) in multiple myeloma (MM), but its impact on gain 1q (+1q) is unknown. METHODS: To address this, 250 patients treated with bortezomib-based induction were analysed. All myeloma samples had fluorescenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hoi Ki Karen, Fung, Chi Yeung, Morgan, Gareth J., Kumar, Shaji, Siu, Lisa, Ip, Ho Wan Alvin, Yip, Sze Fai, Lau, Ka Ngai Harry, Lau, Chi Kuen, Lee, Harold, Leung, Kwan Hung, Kho, Bonnie, Wong, Howard, Ngai, Cheong, Hwang, Yu Yan, Sim, Joycelyn, Kwong, Yok Lam, Chim, Chor Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019371/
https://www.ncbi.nlm.nih.gov/pubmed/35465644
http://dx.doi.org/10.1177/20406207221082043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019371/
https://www.ncbi.nlm.nih.gov/pubmed/35465644
http://dx.doi.org/10.1177/20406207221082043

Ejemplares similares